NPI Details
DR. Rajeswar Rajagopalan, M.D. is an internal medicine in Itasca, IL with 34 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Rajeswar Rajagopalan, M.D. NPI is 1497866784. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
1300 N ARLINGTON HEIGHTS RD STE 130
ITASCA, IL
ZIP 60143-128
Phone: (847) 871-4540
Fax: (847) 871-4597
The NPI 1497866784 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Hemoglobin a1c level (HCPCS:83036)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Magnesium level (HCPCS:83735)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
- Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Vitamin d-3 level (HCPCS:82306)
- Urine microalbumin (protein) level (HCPCS:82043)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Blood potassium level (HCPCS:84132)
- Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
- Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
- Hospital discharge day management, more than 30 minutes (HCPCS:99239)
- Pneumococcal vaccine, 23-valent (HCPCS:90732)
- Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
- Uric acid level, blood (HCPCS:84550)
- Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
The enumeration date for this NPI number is 8/31/2006 and was last updated on 8/17/2023.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 036-090352 | ILLINOIS | Yes |
| 2 | 207RA0401X | Internal Medicine | Addiction Medicine | 036090352 | ILLINOIS | No |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 036090352 | MEDICAID | ILLINOIS | |
